Literature DB >> 17356299

Human cytomegalovirus glycoprotein B genotype correlates with different symptoms of infected infants.

Hong Jin1, Xiuxia Wang, Shuomin Li.   

Abstract

OBJECTIVES: Human cytomegalovirus (HCMV) is the pathogen of cytomegalic inclusion disease of infants. HCMV strains can be classified into four genotypes of glycoprotein B (gB). There are limited data concerning links between clinical symptoms and HCMV genotypes. The aims of the present study were to determine the genotype of HCMV isolates from pediatric patients who have different symptoms on the assumption that the gB genotype may influence the outcomes of congenital and prenatal HCMV infection.
METHODS: The gB types of HCMV were determined in urine specimens from 208 infected infants using nested polymerase chain reaction and restriction fragment length polymorphism.
RESULTS: These data showed the dominance of the gB1 genotype in HCMV-infected infants. The distributions of HCMV gB genotypes in jaundice, malformation, and pneumonia patients are different.
CONCLUSION: There are some relationships between the gB genotypes and the different symptoms of HCMV infection. The four gB genotypes of HCMV may have different clinical outcomes in infected infants. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356299     DOI: 10.1159/000100564

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  8 in total

1.  Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes.

Authors:  Jutte J C de Vries; Els Wessels; Anna M H Korver; Annemiek A van der Eijk; Lisette G Rusman; Aloys C M Kroes; Ann C T M Vossen
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

Review 2.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

3.  Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections.

Authors:  E Paradowska; M Studzińska; D Nowakowska; J Wilczyński; M Rycel; P Suski; Z Gaj; B Kaczmarek; Z Zbróg; Z J Leśnikowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

4.  Mixed infections with distinct cytomegalovirus glycoprotein B genotypes in Polish pregnant women, fetuses, and newborns.

Authors:  M Rycel; W Wujcicka; B Zawilińska; E Paradowska; P Suski; Z Gaj; J Wilczyński; Z Leśnikowski; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-28       Impact factor: 3.267

5.  Genotypes of glycoprotein B gene among the Indian symptomatic neonates with congenital CMV infection.

Authors:  Agniswar Sarkar; Dipanwita Das; Sabbir Ansari; Rajendra Prasad Chatterjee; Lopamudra Mishra; Biswanath Basu; Sanat Kumar Ghosh; Mala Bhattacharyay; Nilanjan Chakraborty
Journal:  BMC Pediatr       Date:  2019-08-22       Impact factor: 2.125

Review 6.  Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.

Authors:  Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.818

7.  Combined genetic variants of human cytomegalovirus envelope glycoproteins as congenital infection markers.

Authors:  Maria-Cristina Arcangeletti; Rosita Vasile Simone; Isabella Rodighiero; Flora De Conto; Maria-Cristina Medici; Davide Martorana; Carlo Chezzi; Adriana Calderaro
Journal:  Virol J       Date:  2015-11-26       Impact factor: 4.099

8.  Inflammatory breast cancer: high incidence of detection of mixed human cytomegalovirus genotypes associated with disease pathogenesis.

Authors:  Hossam Taha Mohamed; Mohamed El-Shinawi; M Akram Nouh; Abdel-Rahman Bashtar; Elsayed Tarek Elsayed; Robert J Schneider; Mona Mostafa Mohamed
Journal:  Front Oncol       Date:  2014-09-11       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.